SML1630

Bendazac

≥98% (HPLC)

• 别名: Bendazolic acid, [(1-Benzyl-1H-indazol-3-yl)oxy]acetic acid
• 经验公式（希尔记法）: C₁₆H₁₄N₂O₃
• CAS号: 20187-55-7
• 分子量: 282.29
• EC號碼: 243-569-2
• MDL號碼: MFCD00866158
• 分類程式碼代碼: 12352200
• PubChem物質ID: 329825514
• NACRES: NA.77

属性

• 品質等級: 200
• 化驗: ≥98% (HPLC)
• 形狀: powder
• 溶解度: DMSO: soluble ≥1 mg/mL; methanol: soluble ≥1 mg/mL
• 儲存溫度: 2-8°C
• SMILES 字串: OC(COC1=NN(CC2=CC=CC=C2)C3=CC=CC=C31)=O
• InChI: 1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)
• InChI 密鑰: BYFMCKSPFYVMOU-UHFFFAOYSA-N
• 基因資訊: human ... XDH(7498)

说明

生化／生理作用

Bendazac (or bendazolic acid) is a non-steroidal anti-inflammatory drug used for joint and muscular pain. Bendazac is an anti-denaturant drug for cataract and other condensation diseases. In addition, Bendazac has been used in studies related to potential treatment and pevention of ischemia and reperfusion syndromes, and was found to inhibit only reversible and irreversible xanthine oxidase.

安全信息

• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3